Jci_page_head_homepage_01 Jci_page_head_homepage_02
Anne Jarry, Céline Bossard, Chantal Bou-Hanna, Damien Masson, Eric Espaze, Marc G. Denis, Christian L. Laboisse
Published in Volume 118, Issue 3
J Clin Invest. 2008; 118(3):1132–1142 doi:10.1172/JCI32140
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5
IFN-γ production upon TGF-β or IL-10 depletion.

Effect of rhTGF-β upon IL-10 depletion. (AC) Mucosa explant cultures were incubated with neutralizing anti–TGF-βRII antibodies (5 μg/ml) or with control goat Ig for 48 h. IFN-γ was examined at the mRNA (real-time PCR; A) and protein (ELISA; B) levels. IL-10 mRNA levels were also determined by real-time PCR (C). Horizontal lines represent mean values of 3 different experiments. (D and E) Mucosa explant cultures were incubated with neutralizing anti–IL-10 antibodies or with the isotype mouse IgG1 (control) for 48 h. The effect on IFN-γ release of incubating IL-10–depleted mucosa explant cultures with rhTGF-β1 (10 ng/ml) was determined into the supernatants, measured by ELISA (D). TGF-β1 mRNA levels were quantified by real-time PCR in control and IL-10–depleted mucosa explant cultures (E). Horizontal lines represent mean values of 4 different experiments. “NS” indicates differences were not significant for the pooled experiments as well as within each experiment.